Tumor Progression
Model Approaches for Pharmacokinetic Data: Physiological Models
Model Approaches for Pharmacokinetic Data: Compartment Models
Self-Evaluation Maintenance Model
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 14, 2026

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
Published on: May 18, 2020
Åsbjørn Schumacher Westvik1, Harald Weedon-Fekjær2, Jan Mæhlen1
1Department of Pathology, Oslo University Hospital, Norway, P.O. Box 4956 Nydalen, 0424, Oslo, Norway.
Mammography screening aims to detect breast cancer early. This study found that models assuming only progressive tumors cannot fully explain incidence trends after screening introduction, suggesting some tumors may regress or become less detectable.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: